http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31545436

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 30
issn 0195-668X
1522-9645
issueIdentifier 1
pageRange 21-30
publicationName European Heart Journal
startingPage 21
bibliographicCitation Wallentin L, Varenhorst C, James S, Erlinge D, Braun OO, Jakubowski JA, Sugidachi A, Winters KJ, Siegbahn A. Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease. Eur Heart J. 2008 Jan;29(1):21–30. doi: 10.1093/eurheartj/ehm545. PMID: 18055486.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb4bab8a500e894c9d1764741ee2d4fc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ef63d031bc45b6637e859ccd89610f2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77f4599249ddc630b67988324e6ee0c6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ec05dd75096fa84f555b2c9aaa8c9b9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e6b972e61b11ce138d72166a0b23c39
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0244a02be46bce1bf5a2fab4bb0d83a7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db08f4b39b070886ce9584d09c6c0d36
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a44dcdc58aef8816e93b7c7a76002e4f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10789f9725fe8def90d92c76c9aada2d
date 2007-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/18055486
https://doi.org/10.1093/eurheartj/ehm545
isPartOf https://portal.issn.org/resource/ISSN/1522-9645
https://portal.issn.org/resource/ISSN/0195-668X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3586
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease
discusses http://id.nlm.nih.gov/mesh/M0021371
http://id.nlm.nih.gov/mesh/M0001864
http://id.nlm.nih.gov/mesh/M0155432
http://id.nlm.nih.gov/mesh/M0017012
http://id.nlm.nih.gov/mesh/M000603803
http://id.nlm.nih.gov/mesh/M0021526
http://id.nlm.nih.gov/mesh/M0016884
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D010975Q000627
http://id.nlm.nih.gov/mesh/D013988Q000031
http://id.nlm.nih.gov/mesh/D013876Q000627
http://id.nlm.nih.gov/mesh/D003324Q000188
http://id.nlm.nih.gov/mesh/D010879Q000627
http://id.nlm.nih.gov/mesh/D001241Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D013988Q000627
http://id.nlm.nih.gov/mesh/D000077144
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000068799
http://id.nlm.nih.gov/mesh/D016896
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_caa134bb5c59c595b9e243985fd916f3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_22438360ceddc08a3109678d6d81edb1
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7346

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243850853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298

Total number of triples: 64.